BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12579988)

  • 1. Nodular lymphocyte predominant Hodgkin lymphoma. An immunophenotypic reappraisal based on a single-institution experience.
    Uherova P; Valdez R; Ross CW; Schnitzer B; Finn WG
    Am J Clin Pathol; 2003 Feb; 119(2):192-8. PubMed ID: 12579988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma.
    Nam-Cha SH; Roncador G; Sanchez-Verde L; Montes-Moreno S; Acevedo A; Domínguez-Franjo P; Piris MA
    Am J Surg Pathol; 2008 Aug; 32(8):1252-7. PubMed ID: 18594468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma].
    Liu YH; Zhuang HG; Lin HL; Wu QL; Luo DL; Li L; Luo XL
    Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):594-8. PubMed ID: 17243292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-positive CD4+CD8+ T-cell population is commonly found in nodular lymphocyte predominant Hodgkin lymphoma.
    Rahemtullah A; Reichard KK; Preffer FI; Harris NL; Hasserjian RP
    Am J Clin Pathol; 2006 Nov; 126(5):805-14. PubMed ID: 17050078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative flow immunophenotypic features of the inflammatory infiltrates of Hodgkin lymphoma and lymphoid hyperplasia.
    Hudnall SD; Betancourt E; Barnhart E; Patel J
    Cytometry B Clin Cytom; 2008 Jan; 74(1):1-8. PubMed ID: 18061945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular hodgkin lymphoma: a histopathologic study.
    Kansal R; Singleton TP; Ross CW; Finn WG; Padmore RF; Schnitzer B
    Am J Clin Pathol; 2002 Jan; 117(1):29-35. PubMed ID: 11789727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nodular lymphocyte predominant Hodgkin lymphoma with clusters of LP Cells, acute inflammation, and fibrosis: a syncytial variant.
    Drakos E; Rassidakis GZ; Leventaki V; Cotta CV; Vega F; Medeiros LJ
    Am J Surg Pathol; 2009 Nov; 33(11):1725-31. PubMed ID: 19730363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-associated Hodgkin lymphoma: a clinicopathologic and immunophenotypic study of 45 cases.
    Thompson LD; Fisher SI; Chu WS; Nelson A; Abbondanzo SL
    Am J Clin Pathol; 2004 May; 121(5):727-38. PubMed ID: 15151213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranodular clusters of activated cells with T follicular helper phenotype in nodular lymphocyte predominant Hodgkin lymphoma: a pilot study of 32 cases from Finland.
    Nathwani BN; Vornanen M; Winkelmann R; Kansal R; Doering C; Hartmann S; Hansmann ML
    Hum Pathol; 2013 Sep; 44(9):1737-46. PubMed ID: 23684509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large B-cell lymphoma with T-cell-rich background and nodules lacking follicular dendritic cell meshworks: description of an insufficiently recognized variant.
    Treetipsatit J; Metcalf RA; Warnke RA; Natkunam Y
    Hum Pathol; 2015 Jan; 46(1):74-83. PubMed ID: 25456392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nodular lymphocyte predominant Hodgkin lymphoma at atypical locations may be associated with increased numbers of large cells and a diffuse histologic component.
    Yang DT; Dunphy CH; Tripp SR; Lagoo AS; Perkins SL
    Am J Hematol; 2008 Mar; 83(3):218-21. PubMed ID: 17918256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgD positive L&H cells identify a unique subset of nodular lymphocyte predominant Hodgkin lymphoma.
    Prakash S; Fountaine T; Raffeld M; Jaffe ES; Pittaluga S
    Am J Surg Pathol; 2006 May; 30(5):585-92. PubMed ID: 16699312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival.
    Muenst S; Hoeller S; Dirnhofer S; Tzankov A
    Hum Pathol; 2009 Dec; 40(12):1715-22. PubMed ID: 19695683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nodular lymphocyte-predominant Hodgkin lymphoma: cytopathologic correlates on fine-needle aspiration.
    Subhawong AP; Ali SZ; Tatsas AD
    Cancer Cytopathol; 2012 Aug; 120(4):254-60. PubMed ID: 22367911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine gene expression profile distinguishes CD4+/CD57+ T cells of the nodular lymphocyte predominance type of Hodgkin's lymphoma from their tonsillar counterparts.
    Atayar C; Poppema S; Visser L; van den Berg A
    J Pathol; 2006 Feb; 208(3):423-30. PubMed ID: 16353293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological variety of floral variant of follicular lymphoma.
    Kojima M; Yamanaka S; Yoshida T; Shimizu K; Murayama K; Ohno Y; Itoh H; Motoori T; Masawa N; Nakamura S
    APMIS; 2006 Sep; 114(9):626-32. PubMed ID: 16948815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD20-Negative Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A 20-Year Consecutive Case Series From a Tertiary Cancer Center.
    Menke JR; Spinner MA; Natkunam Y; Warnke RA; Advani RH; Gratzinger DA
    Arch Pathol Lab Med; 2021 Jun; 145(6):753-758. PubMed ID: 32991677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1 expression and polysomy in lymphocyte-predominant cells of nodular lymphocyte-predominant Hodgkin lymphoma.
    Cho BB; Kelting SM; Gru AA; LeGallo RD; Pramoonjago P; Goldin TA; Heitz CT; Aguilera NS
    Ann Diagn Pathol; 2017 Feb; 26():10-15. PubMed ID: 28038705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of malignant lymphomas in Klang Hospital, a public hospital in Malaysia.
    Peh SC; Kim LH; Thanaletchimy N; Chai SP; Poppema S
    Malays J Pathol; 2000 Jun; 22(1):13-20. PubMed ID: 16329532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphologic, immunphenotypic and clinical discriminators between T-cell/histiocyte-rich large B-cell lymphoma and lymphocyte-predominant Hodgkin lymphoma.
    Mourad WA; Al Thani S; Tbakhi A; Al Omari M; Khafaga Y; Shoukri M; El Weshi A; Al Shabana M; Ezzat A
    Hematol Oncol Stem Cell Ther; 2008; 1(1):22-7. PubMed ID: 20063524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.